Joon Yeun Park

ORCID: 0000-0002-9761-2438
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac tumors and thrombi
  • Sarcoma Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • MRI in cancer diagnosis
  • Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Multiple Myeloma Research and Treatments
  • Medical Imaging Techniques and Applications
  • Lymphoma Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Lung Cancer Research Studies
  • Cancer, Hypoxia, and Metabolism
  • Neurological and metabolic disorders
  • Head and Neck Cancer Studies
  • Nutrition and Health in Aging
  • Breast Cancer Treatment Studies
  • Cancer and Skin Lesions
  • Cardiovascular Disease and Adiposity
  • Adipose Tissue and Metabolism
  • Adrenal and Paraganglionic Tumors
  • Hematological disorders and diagnostics
  • Lanthanide and Transition Metal Complexes
  • Parkinson's Disease Mechanisms and Treatments
  • Oral and Maxillofacial Pathology
  • Neurological disorders and treatments

Myongji Hospital
2020-2024

Hanyang University
2024

Korea Institute of Radiological and Medical Sciences
2010-2018

Korea University Medical Center
2012

Abstract 123 I‐FP‐CIT and 18 F‐FP‐CIT are radiotracers which widely used to diagnose Parkinson's disease (PD). However, our knowledge, no studies date have made head‐to‐head comparisons between F‐FP‐CIT. Therefore, in this study, SPECT/CT was compared with PET/CT the same cohort of subjects. Patients PD essential tremor (ET) underwent PET/CT. Visual semiquantitative analyses were conducted. The specific binding ratio (SBR) putamen caudate (PCR) subjects who analysis showed that striatal...

10.1002/syn.22032 article EN Synapse 2018-02-27

<b><i>Aims:</i></b> It was the aim of this paper to identify prognostic factors in patients with relapsed or refractory B-cell non-Hodgkin's lymphomas, treated by radioimmunotherapy (RIT) radioiodinated human/murine chimeric anti-CD20 monoclonal antibody rituximab (<sup>131</sup>I-rituximab). <b><i>Methods:</i></b> Twenty-four were enrolled prospectively and unlabeled 70 mg a therapeutic activity (median 7.3 GBq)...

10.1159/000346436 article EN Acta Haematologica 2013-01-01

Acinic cell carcinoma is a rare malignant tumor that accounts for 2%-3% of salivary gland tumors. arising from the breast extremely rare, with only approximately 70 cases reported to date. Owing its rarity, previous studies have primarily focused on pathological findings. Herein, we present clinical and radiological features acinic in 33-year-old woman.

10.3348/jksr.2023.0126 article EN cc-by-nc Journal of the Korean Society of Radiology 2024-01-01
Coming Soon ...